Stopped early
Targeted Lower Extremity Joint Training
NCT00765544 · US Department of Veterans Affairs · Updated 23 Sept 2013
- What is being tested
- Anklebot; Lokomat
- For
- Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. Phase 1 and Phase 2.
- Who can join
- Ages 18 years to 75 years. About 10 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Sept 2008, ends Sept 2008. Registered 3 Oct 2008.
- Results
- None posted yet.
In the researchers' words
The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that "task-specific" rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with "foot drop" have difficulty translating task-specific training to normative gait patterns over ground, despite improving speed and endurance. One of the key limitations of the Lokomat is a lack of robot-assisted training for the ankle joint. The Anklebot, an MIT-developed rehabilitation robot for the ankle, has the potential to address this. The device can move throughout three planes and train ankle flexion, extension, inversion and eversion; however, therapy with the Anklebot alone does not train the knee or hip. We plan to test whether subject foot drop and overall gait benefit more from Anklebot therapy alone or a combination of Anklebot and Lokomat.
Sites
- Providence VA Medical CenterProvidence, Rhode Island, United States
